News
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
5d
GlobalData on MSNVertex wins European approval for Alyftrek, bolstering cystic fibrosis strongholdWith its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...
More Australians living with rarer types of cystic fibrosis will be able to access treatment for the first time when expanded ...
13d
AAP on MSN'Transformational': cystic fibrosis drug price slashedAffordable access to life-changing treatment for cystic fibrosis will be expanded to more Australians with a change to the ...
A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...
5d
Zacks.com on MSNVertex Gets EU Nod for New Cystic Fibrosis Drug AlyftrekVRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...
With this reimbursement, approximately 45 people with cystic fibrosis in Australia will become eligible for a CFTR modulator for the first time –– ...
Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...
North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results